New Key Statistics Module, Z-Score and F-Score
NYSE:RCUS Key Ratios
Market Cap $ M | 1,646.61 |
Enterprise Value $ M | 688.61 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.59 |
Price/Sales | 6.10 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 247.00 |
EPS (TTM) $ | -3.09 |
Beneish M-Score | -2.13 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.82 |
EV-to-EBITDA | -2.93 |
PEG | -- |
Shares Outstanding M | 91.43 |
Net Margin (%) | -100.81 |
Operating Margin % | -110.53 |
Pre-tax Margin (%) | -99.60 |
Quick Ratio | 5.14 |
Current Ratio | 5.14 |
ROA % (ttm) | -20.80 |
ROE % (ttm) | -43.08 |
ROIC % (ttm) | -76.97 |
Dividend Yield % | -- |
Altman Z-Score | 1.04 |
RCUS Number of Guru Trades
RCUS Volume of Guru Trades
Gurus Latest Trades with NYSE:RCUS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RCUS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arcus Biosciences Inc Insider Transactions
No Available Data
News about NYSE:RCUS
Total 0- 1